Athira pharma to participate in upcoming may conferences

Bothell, wash., may 02, 2024 (globe newswire) -- athira pharma, inc.  (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that company management will participate in the following upcoming investor conferences in may.
ATHA Ratings Summary
ATHA Quant Ranking